Gal Yosef Co-Founder and CEO Bliss Aesthetics (company pic)
Bliss Aesthetics, an Israeli startup offering a cutting-edge AI-powered platform that is transforming the cosmetic enhancement industry, has raised $17.5 million in a seed funding round. The investment aims to accelerate platform development and expand its presence in the booming aesthetic procedures market, which is projected to reach $200 billion in global revenue within the next decade.
The funding round was led by Shine Capital, with strong participation from Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners. This strategic backing underscores investor confidence in Bliss Aesthetics’ innovative approach to personalized, technology-driven beauty solutions.
With 25% of Americans already having experienced medical aesthetic procedures and a projected 55% increase among men, Bliss empowers patients in this growing market. Leveraging GenAI, Stable Diffusion, and computer vision, the platform allows individuals to realistically visualize potential cosmetic outcomes and choose a board-certified physician who meets their specific expectations. Bliss also simplifies the process by providing information on financing partners, creating a seamless experience. This increased patient engagement, doubling from 40% to 80%, allows doctors to dedicate their time to their skills and efficiently grow their businesses.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at [email protected].
Thank you.
Founded in 2022, Bliss Aesthetics’ groundbreaking platform delivers “bespoke, effortless support, securing tailored payment plans and linking you with the elite of board-certified surgeons.” Bliss is the first system of intelligence for cosmetic enhancement. By combining an AI-powered decision engine with intelligent matchmaking and 24/7 customer assistance, Bliss equips patients to make informed, confident decisions and gives surgeons the tools to serve their patients better while having more time to focus on performing procedures.
With “stellar credentials and rave reviews,” their network guarantees extraordinary care and results.
“This funding will give us the ability to harness the momentum we are experiencing, building on the 500% growth of our provider base in our patient-to-physician app since our launch while expanding to five new states across the country,” said Gal Yosef, Bliss’ Co-Founder and CEO of Bliss Aesthetics. “By combining intelligent matchmaking with AI tools, we equip patients to make informed, confident, and financially savvy decisions and give doctors the ability to deliver better outcomes to more patients with less administrative burden.”
